Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 325Pancreatic Neoplasms 189Carcinoma, Hepatocellular 119Stomach Neoplasms 116Colonic Neoplasms 87Esophageal Neoplasms 85Carcinoma, Non-Small-Cell Lung 84Breast Neoplasms 80Rectal Neoplasms 78Ovarian Neoplasms 65Neoplasm Metastasis 61Lung Neoplasms 61Neoplasms 57Cholangiocarcinoma 55Liver Neoplasms 47Melanoma 46Gastrointestinal Neoplasms 46Prostatic Neoplasms 43Biliary Tract Neoplasms 37Endometrial Neoplasms 34Squamous Cell Carcinoma of Head and Neck 32Sarcoma 32Carcinoma, Renal Cell 30Esophageal Squamous Cell Carcinoma 28Uterine Cervical Neoplasms 27Head and Neck Neoplasms 25Adenocarcinoma Of Esophagus 24Urinary Bladder Neoplasms 23Small Cell Lung Carcinoma 20Triple Negative Breast Neoplasms 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dihydropyrimidine Dehydrogenase Deficiency × Gastrointestinal × 30 days × Clear all
NCT04541381 2026-05-07

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

University of Chicago

Phase NA Suspended
860 enrolled
BreastGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡